What next for newly diagnosed glioblastoma?

被引：25

作者：

Domingo-Musibay, Evidio ^{[1
]}

Galanis, Evanthia ^{[1
]}

机构：

[1] Mayo Clin, Div Med Oncol, Rochester, MN 55905 USA

来源：

FUTURE ONCOLOGY | 2015年 / 11卷 / 24期

关键词：

bevacizumab; glioblastoma; newly diagnosed; novo-TTF; radiation therapy; temozolomide; INTEGRATED GENOMIC ANALYSIS; CARMUSTINE BCNU WAFERS; RANDOMIZED PHASE-III; GENE-THERAPY; OPEN-LABEL; ADJUVANT TEMOZOLOMIDE; LOCAL CHEMOTHERAPY; STANDARD TREATMENT; RADIATION-THERAPY; GLIADEL WAFERS;

D O I：

10.2217/fon.15.258

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Glioblastoma is the most common primary brain tumor in adults. Despite current multimodality treatment including surgical resection and temozolomide-based chemoradiotherapy, median survival is only 14-16 months. Characterization of molecular alterations in glioblastoma has identified prognostic subgroups and therapeutic opportunities for clinical trials across glioblastoma subsets. Following a number of negative Phase III trials testing temozolomide dose intensification and angiogenesis inhibition, recent interim analysis data indicate survival prolongation with use of a device (Optune (TM)) delivering alternating electrical field therapy in newly diagnosed glioblastoma patients. In this review, we present an overview of the data supporting the current standard of care and discuss novel experimental therapies in early and late phase clinical testing including devices, small molecule drugs, angiogenesis inhibitors, oncolytic virotherapy and immunotherapy.

引用

页码：3273 / 3283

页数：11

共 53 条

[21]

Kleinberg L, 2013, J CLIN ONCOL, V31

[22] Giant cell glioblastoma: A glioblastoma subtype with distinct epidemiology and superior prognosis [J].

Kozak, Kevin R. ;

Moody, John S. .

NEURO-ONCOLOGY, 2009, 11 (06) :833-841

[23] PHASE I CLINICAL TRIAL OF ONCOLYTIC VIRUS DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO-IMMUNOTHERAPY [J].

Lang, Frederick F. ;

Conrad, Charles ;

Gomez-Manzano, Cande ;

Tufaro, Frank ;

Sawaya, Raymond ;

Weinberg, Jeffrey ;

Prabhu, Sujit ;

Fuller, Gregory ;

Aldape, Kenneth ;

Fueyo, Juan .

NEURO-ONCOLOGY, 2014, 16

[24] Going viral with cancer immunotherapy [J].

Lichty, Brian D. ;

Breitbach, Caroline J. ;

Stojdl, David F. ;

Bell, John C. .

NATURE REVIEWS CANCER, 2014, 14 (08) :559-567

[25] The 2007 WHO classification of tumours of the central nervous system (vol 114, pg 97, 2007) [J].

Louis, David N. ;

Ohgaki, Hiroko ;

Wiestler, Otmar D. ;

Cavenee, Webster K. ;

Burger, Peter C. ;

Jouvet, Anne ;

Scheithauer, Bernd W. ;

Kleihues, Paul .

ACTA NEUROPATHOLOGICA, 2007, 114 (05) :547-547

[26] Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial [J].

Malmstrom, Annika ;

Gronberg, Bjorn Henning ;

Marosi, Christine ;

Stupp, Roger ;

Frappaz, Didier ;

Schultz, Henrik ;

Abacioglu, Ufuk ;

Tavelin, Bjorn ;

Lhermitte, Benoit ;

Hegi, Monika E. ;

Rosell, Johan ;

Henriksson, Roger .

LANCET ONCOLOGY, 2012, 13 (09) :916-926

[27] Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme [J].

McGirt, Matthew J. ;

Than, Khoi D. ;

Weingart, Jon D. ;

Chaichana, Kaisorn L. ;

Attenello, Frank J. ;

Olivi, Alessandro ;

Laterra, John ;

Kleinberg, Lawrence R. ;

Grossman, Stuart A. ;

Brem, Henry ;

Quinones-Hinojosa, Alfredo .

JOURNAL OF NEUROSURGERY, 2009, 110 (03) :583-588

[28] Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity [J].

Miglierini, Petra ;

Bouchekoua, Mohamed ;

Rousseau, Benoit ;

Hieu, Phong Dam ;

Malhaire, Jean-Pierre ;

Pradier, Olivier .

CLINICAL NEUROLOGY AND NEUROSURGERY, 2012, 114 (09) :1222-1225

[29] Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients [J].

Mitchell, Duane A. ;

Batich, Kristen A. ;

Gunn, Michael D. ;

Huang, Min-Nung ;

Sanchez-Perez, Luis ;

Nair, Smita K. ;

Congdon, Kendra L. ;

Reap, Elizabeth A. ;

Archer, Gary E. ;

Desjardins, Annick ;

Friedman, Allan H. ;

Friedman, Henry S. ;

Herndon, James E., II ;

Coan, April ;

McLendon, Roger E. ;

Reardon, David A. ;

Vredenburgh, James J. ;

Bigner, Darell D. ;

Sampson, John H. .

NATURE, 2015, 519 (7543) :366-+

[30] Benefits of Interferon-β and Temozolomide Combination Therapy for Newly Diagnosed Primary Glioblastoma With the Unmethylated MGMT Promoter A Multicenter Study [J].

Motomura, Kazuya ;

Natsume, Atsushi ;

Kishida, Yugo ;

Higashi, Hiroyuki ;

Kondo, Yutaka ;

Nakasu, Yoko ;

Abe, Tatsuya ;

Namba, Hiroki ;

Wakai, Kenji ;

Wakabayashi, Toshihiko .

CANCER, 2011, 117 (08) :1721-1730

← 1 2 3 4 5 6 →